Prostate News Archive
14-Mar-2011
Prostate cancer tests improve with technology
When 54-year-old Jeff Rolf went in for his annual physical three years ago, he did not expect to come away with news of an abnormal PSA level and, eventually, a prostate cancer diagnosis. Prostate Cancer Tests Improving
prostate cancer tests may be improving, thanks to a new screening method giving more specific results. The new test has recently been submitted to the Food and Drug Administration for approval. prostate cancer has long been detected by screening levels of prostate-specific antigen (PSA). An increased PSA level indicates necessity for further testing, usually in the form of a biopsy. High... Adamis Pharmaceuticals Files IND For Product Candidate To Treat Prostate Cancer
Adamis Pharmaceuticals Corporation (OTCBB: ADMP) announced that it has recently submitted to the FDA an Investigational New Drug (IND) application for APC-100 to treat prostate cancer (PCa). Following approval by the FDA of the IND, Adamis plans to begin Phase 1/2a clinical studies with APC-100 in men with castrate resistant prostate cancer (CRPR). Each patient will be assessed for toxicity ... Inhibiting Disease Metastasis By Trapping Prostate Cancer Cells
When prostate cancer stem cells (CSCs) were enclosed in self-assembling nanomaterials made of peptides (SAP), the SAP stopped cancer stem cell colony formation and also stopped the division of cancer cells in laboratory cultures (in vitro). According to the international team of researchers who built and tested the nano-sized traps and published their results in a recent issue of Cell ... Genetic detective
Two generations of family help bid to track roots of prostate cancer
Back to Prostate News Archive
